39
Participants
Start Date
December 31, 2005
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Cetuximab Plus P-HDFL
Cetuximab 400 mg/m2, IV, day 1 of cycle 1; then weekly IV 250 mg/m2. Cisplatin 24-hour IV infusion 35 mg/m2/day, plus HDFL (5-FU 2,000 mg/m2 and leucovorin 300 mg/m2), day 1 and day 8. HDFL IV, day 15.
Department of Oncology, National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
National Health Research Institutes, Taiwan
OTHER
Chang Gung Memorial Hospital
OTHER
Tri-Service General Hospital
OTHER
National Taiwan University Hospital
OTHER